Jupiter Neurosciences Files 8-K: Material Agreement
Ticker: JUNS · Form: 8-K · Filed: Dec 4, 2024 · CIK: 1679628
Sentiment: neutral
Topics: material-agreement, disclosure, exhibits
TL;DR
JUPITER NEUROSCIENCES SIGNED A BIG DEAL - FILING 8-K
AI Summary
On December 2, 2024, Jupiter Neurosciences, Inc. entered into a material definitive agreement. The company also made a Regulation FD disclosure and filed financial statements and exhibits. The exact nature of the agreement and the details of the disclosures and exhibits are not specified in this filing summary.
Why It Matters
This filing indicates a significant event for Jupiter Neurosciences, Inc., potentially involving a new contract, partnership, or financial transaction that could impact its business operations and future prospects.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, which could be positive or negative depending on its terms, introducing a degree of uncertainty.
Key Players & Entities
- JUPITER NEUROSCIENCES, INC. (company) — Registrant
- December 2, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-41265 (filing_id) — SEC File Number
- 47-4828381 (tax_id) — I.R.S. Employer Identification Number
- 1001 North US HWY 1 , Suite 504 Jupiter , Florida 33477 (address) — Address of principal executive offices
- (561) 406-6154 (phone_number) — Registrant's telephone number
FAQ
What is the specific nature of the material definitive agreement entered into by Jupiter Neurosciences, Inc. on December 2, 2024?
The filing does not specify the exact nature of the material definitive agreement, only that one was entered into on December 2, 2024.
What information is provided in the Regulation FD disclosure mentioned in the filing?
The filing states that a Regulation FD Disclosure was made, but the specific content of this disclosure is not detailed in the provided summary.
What types of financial statements and exhibits are included with this 8-K filing?
The filing indicates that Financial Statements and Exhibits are included, but their specific content is not detailed in the provided summary.
When was Jupiter Neurosciences, Inc. incorporated, and in which state?
Jupiter Neurosciences, Inc. was incorporated in Delaware.
What is the principal executive office address and phone number for Jupiter Neurosciences, Inc.?
The principal executive office is located at 1001 North US HWY 1, Suite 504, Jupiter, Florida 33477, and the phone number is (561) 406-6154.
Filing Stats: 991 words · 4 min read · ~3 pages · Grade level 11.7 · Accepted 2024-12-04 16:57:34
Key Financial Figures
- $0.0001 — "Offering") of common stock, par value $0.0001 per share (the "Common Stock"). Pursuan
- $4.00 — erwriters at a public offering price of $4.00 per share (the "Offering Price"), pursu
- $3.72 — the underwriters at a purchase price of $3.72 per share representing a 7% underwritin
- $175,000 — relating to the offering, not to exceed $175,000. The Offering closed on December 4, 2
- $11,000,000 — nderwriters for total gross proceeds of $11,000,000. After deducting the underwriting commi
- $9.5 million — received net proceeds of approximately $9.5 million. The foregoing summary of the Underwr
Filing Documents
- form8-k.htm (8-K) — 44KB
- ex10-1.htm (EX-10.1) — 287KB
- ex99-1.htm (EX-99.1) — 14KB
- ex99-2.htm (EX-99.2) — 12KB
- ex99-1_001.jpg (GRAPHIC) — 6KB
- ex99-2_001.jpg (GRAPHIC) — 29KB
- 0001493152-24-048687.txt ( ) — 648KB
- juns-20241202.xsd (EX-101.SCH) — 3KB
- juns-20241202_lab.xml (EX-101.LAB) — 33KB
- juns-20241202_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. JUPITER NEUROSCIENCES, INC. Dated: December 4, 2024 By: /s/ Christer Rosn Name: Christer Rosn Title: Chief Executive Officer